NBTX

NANOBIOTIX

NBTX·63009J107·US·ADR·Healthcare - Biotechnology-13D/G

NBTX (NANOBIOTIX) is held by 11 institutional investors as of Q1 2026. Largest holders: MORGAN STANLEY ($1.1M), Optiver Holding B.V. ($416,776), MARSHALL WACE, LLP ($285,207). Net institutional sentiment: Mixed.

11
Holders
Avg rating(4 Elite)
$2.3M
Total Value
33% (12)
Fund Consensus
3 buying - 6 selling

No verdict yet — fewer than 2 funds hold NBTX.

13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
36,274(+58.2%)$1.1M0.0%+68.85%
36
Decreased
13,501(-16.8%)$416,7760.0%+95.80%
0
Decreased
9,239(-2.8%)$285,2070.0%+84.91%
0
Increased
5,557(+263.2%)$171,5450.0%+64.69%
25
Decreased
3,559(-1.1%)$109,8660.0%+103.64%
0
Decreased
2,281(-2.6%)$70,4090.0%+86.48%
0
Decreased
1,825(-30.5%)$56,0000.0%+92.81%
0
Unchanged
500$15,4350.0%+84.91%
0
Unchanged
200$6,1740.0%+84.91%
0
Unchanged
13$3940.0%+784.55%
0
New
1$310.0%+31.03%
17
Exited
0(-100.0%)$390,0110.0%+41.12%
0

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used